IL6 and lung carcinoma: Previous clinical studies which have assessed changes in plasma cytokine concentration during radiotherapy for lung cancer have demonstrated increased circulating TGF-β143, IL-6 and IL-1044, and MCP-3, δMIP-1a, and IP-1045.